The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations: from PAPA to PAMI syndrome and beyond

H. W. Klötgen, H. Beltraminelli, N. Yawalkar, M. E. van Gijn, D. Holzinger, L. Borradori

Research output: Contribution to journalLetterAcademicpeer-review

Abstract

Mutations in the PSTPIP1 gene encoding proline-serine-threonine-phosphatase interactive protein 1 were first identified in an autosomal dominant syndrome called PAPA associated with pyogenic sterile arthritis, pyoderma gangrenosum (PG) and cystic acne.1,2 . We report a patient with an autoinflammatory syndrome called PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome.3 A 23-year-old man had a 3-year-history of skin ulcerations. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)982-983
Number of pages2
JournalBritish Journal of Dermatology
Volume178
Issue number4
Early online date18 Nov 2017
DOIs
Publication statusPublished - 1 Apr 2018

Fingerprint

Dive into the research topics of 'The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations: from PAPA to PAMI syndrome and beyond'. Together they form a unique fingerprint.

Cite this